Ami Organics Limited has announced that its Board of Directors will meet on February 21, 2025, to consider a stock split as part of its capital restructuring plans. The company disclosed this in a regulatory filing with the BSE and NSE.
According to the official statement, the Board will deliberate on the sub-division or split of existing equity shares of face value ₹10 each, subject to shareholder approval and necessary regulatory clearances. The decision is expected to enhance liquidity and make the stock more accessible to retail investors.
Additionally, in compliance with SEBI’s insider trading regulations, Ami Organics has announced the closure of its trading window for designated persons and insiders. The trading restrictions will remain in effect until further instructions.
Q3 FY25 Financial Highlights:
• Revenue: The company’s revenue from operations surged 65.2% year-on-year (YoY) to ₹275 crore in Q3 FY25, up from ₹166.4 crore in the same quarter last year.
• Gross Margin: Gross margins improved to 46.2%, an increase of 333 basis points YoY, reflecting enhanced operational efficiency.
• EBITDA: Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) stood at ₹68.7 crore, marking a 159% YoY increase from ₹26.5 crore in Q3 FY24.
• EBITDA Margin: The EBITDA margin expanded to 25.0%, up from 15.9% in the corresponding quarter of the previous year.
• Profit After Tax (PAT): Net profit more than doubled to ₹45.4 crore, compared to ₹17.8 crore in Q3 FY24.
